"Designing Growth Strategies is in our DNA"

Ellagic Acid Market Size, Share, and Industry Analysis By Source (Natural and Synthetic), By Purity (90%, 95%, 40%, and Others), By Application (Cosmetics and Personal Care, Food Supplements, Research, and Others), By End-user (Cosmeceutical Companies, Nutraceutical Companies, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI110797 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global ellagic acid market is witnessing substantial growth due to the increasing shift of people toward the adoption of natural and plant-based ingredients for various products, as well as increasing research activities associated with ellagic acid for various diseases with no definite treatment. Ellagic acid is a phytopharmaceutical pharmaceutical that is derived from botanicals. The acid is found in many fruits, nuts, and vegetables, such as pomegranates, walnuts, blackberries, raspberries, strawberries, and many other plant foods.

Ellagic acid is a dimeric derivative of gallic acid and is known for its antioxidant properties, which contributes to its significant health benefits against a wide range of diseases. It has various benefits, such as anti-inflammatory, anti-cancer, and cardioprotective properties. Furthermore, it is also used in cosmetic applications as it is an efficient skin whitener, and also a suppressor of pigmentation. Such benefits associated with ellagic acid are expected to boost the growth of the market.

In May 2024, the researchers at Edith Cowan University (ECU) investigated the effects of antioxidant properties of ellagic acid dietary intervention on the treatment of non-alcoholic fatty liver disease (NAFLD) to reverse the damage caused by fatty liver disease. Such studies boost the adoption of ellagic acid for various disease indications and propel the growth of the market.

Ellagic Acid Market Driver

Growing Consumer Shift Toward Nutraceuticals to Expand Market Growth

Increasing awareness of lifestyle diseases has led to a greater shift of focus on preventive healthcare. Nutraceuticals have emerged as beneficial health products showing efficacy in dealing with a number of health problems. Ellagic acid is marketed for its natural antioxidant, potential anti-aging, and skin-brightening benefits, which are appealing to health-conscious consumers.

Additionally, nutraceuticals have therapeutic potential with minimum side effects as compared to conventional pharmaceuticals. Further, an increase in the shift of people to nutraceuticals adoption is propelling the growth of the market.

  • For instance, in February 2024, according to a report published by Local Circles, a comprehensive national survey was conducted to observe how Indian households consume various nutraceutical products in 318 districts of India, and over 47,000 responses were received. It revealed that seven out of ten consumers surveyed confirmed the regular intake of various nutraceuticals, ranging from vitamins to dietary supplements. Such large adoption of nutraceuticals drives the growth of the ellagic acid market.

To know how our report can help streamline your business, Speak to Analyst

The Local Circles projected that out of 47,000 responses, around 71.0% of people in India are regularly taking nutraceutical products.

Ellagic Acid Market Restraint

High Costs Associated with the Acid Coupled with Presence of Counterfeit Products May Inhibit Market Growth

The process of extraction of ellagic acid, with higher purity, can be costly, which affects the overall price of the products containing it.

  • As per a commercial website, twenty-five of ellagic acid by Otto Chemie Pvt. Ltd. costs around USD 152.7. Such high costs may hamper the growth of the market over the forecast period.

The presence of adulterated and counterfeit acid products negatively impacts the market due to a rise in quality and safety concerns. Furthermore, counterfeit products erode consumer trust and damage the market's reputation.

  • For instance, in August 2021, the American Botanical Council (ABC) announced the latest installation of the ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP). The council was formed after they found that pomegranate juices, a good source of ellagic acid, had been diluted with water or mixed with undeclared amounts of cheaper fruit juices. Further, pomegranate products contain little to no actual pomegranate with unidentified low-cost ingredients that give false, misleading information regarding their purity and the true value of ellagic acid present in the product. Such adulterated products present in the market hinder consumer trust and restrain the market growth.

Ellagic Acid Market Opportunity

Soaring Research and Development Activities to Create Growth Opportunities for Industry Players

In the recent years, the demand for ellagic acid therapeutic drugs has surged. However, the acid has been found to have limited use in the therapeutic applications due to its low water solubility and bioavailability. Rising research and development activities to incorporate ellagic acid with lipid nanoparticles is an innovative approach to enhance the bioavailability of ellagic acid. Such advancements may drive the expansion of the market during the forecast period.

Key Insights

The report covers the following key insights:

  • Prevalence of Key Chronic Diseases, By Key Countries, 2023
  • Overview: Ellagic Acid Benefits
  • Key Industry Developments (Mergers, Acquisitions, Partnerships, and Product Launches)
  • Impact of COVID-19 on the Market

Segmentation

By Source

By Purity

By Application

By End-user

By Geography

  • Natural
  • Synthetic
  • 90%
  • 95%
  • 40%
  • Others
  • Cosmetics and Personal Care
  • Food Supplements
  • Research
  • Others
  • Cosmeceutical Companies
  • Nutraceutical Companies
  • Pharmaceutical & Biotechnology Companies
  • Others
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Analysis by Source

Based on source, the market is divided into natural and synthetic.

The synthetic segment held a significant share of the market. The rising demand for high quality and purity, as well as the production of ellagic acid by synthetic methods, can be more cost-effective than extracting it from natural sources. These factors make it more feasible for pharmaceuticals, nutraceuticals, and cosmetic manufacturers to use it for their desired applications. Such benefits associated with the synthetic processed ellagic acid boost the segment growth.

Analysis by Purity

Based on purity, the market is segmented into 90%, 95%, 40%, and others.

The 95% purity held a significant share of the market. The growth of the segment is augmented by the increasing demand for higher purity of ellagic acid for a variety of applications. For the manufacturing of vitamins and nutraceutical products, the high purity of ellagic acid is required. Such requirements for high-grade, pure, and safe reagents propel the segment growth.

Analysis by Application

Based on application, the market is segmented into cosmetics and personal care, food supplements, research, and others.

The cosmetics and personal care segment holds a considerable share of the market. The growth of the segment is attributed to the antioxidant properties associated with ellagic acid that help to protect the skin from oxidative stress and damage. The acid is used to reduce hyperpigmentation and uneven skin tone, making it a prominent component for skin-brightening and anti-aging products. The benefits associated with ellagic acid shift the focus of cosmetics manufacturing companies to launch more skin care products containing ellagic acid. Additionally, an increase in product launches with ellagic acid constituents for cosmetics applications is expected to boost the growth of the segment in the market.

  • For instance, in November 2020, SILAB, a cosmetic manufacturing company that markets more than 100 cosmetic active ingredients of natural origin, launched ACNESIUM, a natural active ingredient composed of ellagitannins, primarily punicalagin and derivatives, as well as punicalin, derivatives of 2,3-(S)-hexahydroxydiphenoyl and ellagic acid and used to treat patients suffering from slight to moderate acne. Such product launches boost the growth of the segment.

Analysis by End-user

Based on end-user, the market is subdivided into cosmeceutical companies, nutraceutical companies, pharmaceutical & biotechnology companies, and others.

The nutraceutical companies held a significant portion of the market. Owing to the increased demand for natural and plant-based supplements and the shift of people toward preventive healthcare led to the increasing research activities and product launches by nutraceutical companies. This scenario is expected to propel the growth of the segment in the market.

  • For instance, in May 2024, Verdure Sciences conducted a study with the National Center for Natural Products Research (NCNPR) at the University of Mississippi to study the benefits of the pomegranate extract branded as Pomella. The study revealed that oral supplementation of Pomella has significant beneficial effects on the gut microbiome. Such scenarios augment the growth of the segment in the market.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a significant share of the global ellagic acid market in 2023. The growth of the market in the region is attributed to increasing awareness of the adoption of plant-based products. Further, rising research and development activities for the launch of new advanced cosmetics and dietary supplements for various skin and health conditions is contributing to the market growth. Additionally, increasing approvals for the ellagic acid-containing products to enhance the cognitive functions leads to the regional market growth.

  • For instance, in April 2024, PLT Health Solutions was awarded a license from the Natural and Non-Prescription Health Products Directorate (NNHPD) of Health Canada for its Nutricog Cognitive Performance Complex. Clinical trials have demonstrated that this patented ingredient significantly enhances various cognitive functions, such as learning, memory, sustained attention, working memory, and executive function, in comparison to a placebo. The formulation combines Haritaki (Terminalia chebula) and Boswellia (Boswellia serrata) and is standardized to contain gallic acid, ellagic acid, and amyrins, which are the essential compounds in these botanicals.

Europe has a considerable share of the market based on the demand for ellagic acid. This was owing to the presence of key players in the market with rising awareness toward preventive lifestyles and increasing demand for cosmetics and beauty products leading toward the growth of the region in the market.

Moreover, the Asia Pacific region is expected to grow during the forecast period. The growth of the region is attributed to a rising patient pool and awareness regarding healthy lifestyles, leading to the shift of people to plant-based drugs and supplements. Such scenarios are expected to propel the growth of the regional market.

Key Players Covered

The global ellagic acid market is fragmented, with a diverse group of companies, ranging from established companies to the emerging players.

The report includes the profiles of the following key players:

  • Merck KGaA (Germany)
  • Thermo Fisher Scientific Inc.  (U.S.)
  • MP BIOMEDICALS. (U.S.)
  • Otto Chemie Pvt. Ltd. (India)
  • BPS Bioscience, Inc. (U.S.)
  • Glentham Life Sciences Limited (U.K.)
  • Honghao Herb (China)
  • Nektium Pharma S.L. (Spain)
  • Shanghai Kanwinn Pharmchem Ltd. (China)
  • Cambridge Commodities Inc. (U.S.)

Key Industry Developments

  • In May 2024, Glentham Life Sciences Limited announced the availability of their products across the European Union in collaboration with their German subsidiary DDP terms. The collaboration would lead to the easy availability of ellagic acid across the EU.
  • In September 2020, Glentham Life Sciences Limited acquired a manufacturing facility in Corsham, Wiltshire, U.K. The facility aimed to manufacture new products with enhanced capabilities, a high level of product quality, and customer service.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann